Hyperuricemia Drugs Global Market Report 2024

Hyperuricemia Drugs Global Market Report 2024

Including: 1) By Type: Asymptomatic Hyperuricemia; Symptomatic Hyperuricemia2) By Drugs: Nonsteroidal Anti-Inflammatory Drugs; Xanthine Oxidase Inhibitors; Selective Uric Acid Reabsorption Inhibitor (SURI); Uricosuric Agents3) By Diseases: Gout; Kidney Stone4) By End-User: Hospitals; Homecare; Specialty ClinicsCovering: Pfizer Inc.; Merck & Co.; Bayer AG; Sanofi SA; Myers Squibb Bristol Company


Hyperuricemia Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperuricemia drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for hyperuricemia drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hyperuricemia drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Asymptomatic Hyperuricemia; Symptomatic Hyperuricemia; Other Types

2) By Drugs: Nonsteroidal Anti-Inflammatory Drugs; Xanthine Oxidase Inhibitors; Selective Uric Acid Reabsorption Inhibitor (SURI); Uricosuric Agents; Other Drugs

3) By Diseases: Gout; Kidney Stone; Other Diseases

4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users

Companies Mentioned: Pfizer Inc.; Merck & Co.; Bayer AG; Sanofi SA; Myers Squibb Bristol Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Hyperuricemia Drugs Market Characteristics
3. Hyperuricemia Drugs Market Trends And Strategies
4. Hyperuricemia Drugs Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Hyperuricemia Drugs Market Size and Growth
5.1. Global Hyperuricemia Drugs Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Hyperuricemia Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hyperuricemia Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Hyperuricemia Drugs Market Segmentation
6.1. Global Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Asymptomatic Hyperuricemia
Symptomatic Hyperuricemia
Other Types
6.2. Global Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs
Xanthine Oxidase Inhibitors
Selective Uric Acid Reabsorption Inhibitor (SURI)
Uricosuric Agents
Other Drugs
6.3. Global Hyperuricemia Drugs Market, Segmentation By Diseases, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Gout
Kidney Stone
Other Diseases
6.4. Global Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End-Users
7. Hyperuricemia Drugs Market Regional And Country Analysis
7.1. Global Hyperuricemia Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hyperuricemia Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Hyperuricemia Drugs Market
8.1. Asia-Pacific Hyperuricemia Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Hyperuricemia Drugs Market
9.1. China Hyperuricemia Drugs Market Overview
9.2. China Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Hyperuricemia Drugs Market
10.1. India Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Hyperuricemia Drugs Market
11.1. Japan Hyperuricemia Drugs Market Overview
11.2. Japan Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Hyperuricemia Drugs Market
12.1. Australia Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Hyperuricemia Drugs Market
13.1. Indonesia Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Hyperuricemia Drugs Market
14.1. South Korea Hyperuricemia Drugs Market Overview
14.2. South Korea Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Hyperuricemia Drugs Market
15.1. Western Europe Hyperuricemia Drugs Market Overview
15.2. Western Europe Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Hyperuricemia Drugs Market
16.1. UK Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Hyperuricemia Drugs Market
17.1. Germany Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Hyperuricemia Drugs Market
18.1. France Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Hyperuricemia Drugs Market
19.1. Italy Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Hyperuricemia Drugs Market
20.1. Spain Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Hyperuricemia Drugs Market
21.1. Eastern Europe Hyperuricemia Drugs Market Overview
21.2. Eastern Europe Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Hyperuricemia Drugs Market
22.1. Russia Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Hyperuricemia Drugs Market
23.1. North America Hyperuricemia Drugs Market Overview
23.2. North America Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Hyperuricemia Drugs Market
24.1. USA Hyperuricemia Drugs Market Overview
24.2. USA Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Hyperuricemia Drugs Market
25.1. Canada Hyperuricemia Drugs Market Overview
25.2. Canada Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Hyperuricemia Drugs Market
26.1. South America Hyperuricemia Drugs Market Overview
26.2. South America Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Hyperuricemia Drugs Market
27.1. Brazil Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Hyperuricemia Drugs Market
28.1. Middle East Hyperuricemia Drugs Market Overview
28.2. Middle East Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Hyperuricemia Drugs Market
29.1. Africa Hyperuricemia Drugs Market Overview
29.2. Africa Hyperuricemia Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hyperuricemia Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hyperuricemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Hyperuricemia Drugs Market Competitive Landscape And Company Profiles
30.1. Hyperuricemia Drugs Market Competitive Landscape
30.2. Hyperuricemia Drugs Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Merck & Co.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Bayer AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Sanofi SA
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Myers Squibb Bristol Company
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Hyperuricemia Drugs Market Other Major And Innovative Companies
31.1. AstraZeneca plc
31.2. Novartis AG
31.3. GlaxoSmithKline PLC
31.4. Roche Holdings Inc.
31.5. Amgen Inc.
31.6. Boehringer Ingelheim International GmbH
31.7. Teva Pharmaceuticals
31.8. Regeneron Pharmaceuticals Inc.
31.9. Teijin Pharma Limited
31.10. Sun Pharmaceutical Industries Ltd.
31.11. Dr. Reddy’s Laboratories Ltd.
31.12. Hikma Pharmaceuticals PLC
31.13. Amneal Pharmaceuticals Inc.
31.14. Glenmark Pharmaceuticals Ltd.
31.15. Kissei Pharmaceutical Co. Ltd.
32. Global Hyperuricemia Drugs Market Competitive Benchmarking
33. Global Hyperuricemia Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Hyperuricemia Drugs Market
35. Hyperuricemia Drugs Market Future Outlook and Potential Analysis
35.1 Hyperuricemia Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Hyperuricemia Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Hyperuricemia Drugs Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings